MedTrace Logo

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

NCT05103410 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-02-06

No results posted yet for this study

Summary

The analgesic effect of perioperative use of aripiprazole has not been fully investigated.

So, this study aims to test the effects of aripiprazole versus placebo in reducing postoperative pain following laparoscopic hysterectomy and to explore the potential side effects.

Conditions

  • Anesthesia
  • Analgesia
  • Hysterotomy

Interventions

DRUG

ARIPiprazole 30 MG

Patients will receive Aripiprazole 30 mg tablet orally 3 h before surgery

DRUG

Placebo

Patients will receive placebo tablet which is identical in appearance, size, shape, and color to aripiprazole 3 h before surgery

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-10
Primary Completion
2023-01-01
Completion
2023-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05103410 on ClinicalTrials.gov